Lilly - November 2023 - case study 2

Start date:

Developing a pathway for the early and accurate diagnosis of Alzheimer’s Disease (AD) including biomarker assessment via cerebrospinal fluid (CSF)

NHS Organisation(s) Oxford Health NHS Foundation Trust, Greater Manchester Mental Health NHS Foundation Trust, University Hospitals Sussex NHS Trust, Sheffield Teaching Hospitals NHS Foundation Trust
Project focus Cancer/Oncology
Project Type Joint Working
Company Lilly
Link for further information
Open the Lilly website

Last modified: 22 March 2024

Last reviewed: 29 May 2024